NFKB1 and Insulin resistance: On one hand, CRP could induce the expression of acute-phase response proteins in the liver and activate inflammatory signaling pathways such as NF-κB, thereby promoting the release of inflammatory factors such as TNF-α and IL-6, interfering with the downstream signal transduction of insulin receptors, and inducing peripheral tissue insulin resistance (34).